Ghisallo Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Ghisallo Capital Management LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $19.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$19.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Caris Life Sciences Inc. (CAI)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CAICaris Life Sciences Inc. | 250,000 | $4.5M |
| ALMSALUMIS INC. | 100,000 | $2.2M |
| DNLIDenali Therapeutics Inc. | 100,000 | $1.9M |
| PRAXPraxis Precision Medicines, Inc. | 5,000 | $1.6M |
| KMTSKestra Medical Technologies Ltd. | 75,000 | $1.5M |
| PCVXVaxcyte, Inc. | 25,000 | $1.5M |
| CADLCandel Therapeutics, Inc. | 200,000 | $980K |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 11,000 | $803K |
| EIKNEikon Therapeutics Inc. | 70,000 | $741K |
| IRONDisc Medicine, Inc. | 10,000 | $639K |
| ROIVRoivant Sciences Ltd. | 19,500 | $540K |
| CMIIUColumbus Circle Capital Corp II Unit | 50,000 | $497K |
| IXHLIncannex Healthcare Inc. | 162,855 | $489K |
| AKTSAktis Oncology Inc. | 25,000 | $447K |
| MPLTMapLight Therapeutics, Inc. | 20,000 | $407K |
| MANEVeradermics Incorporated | 5,000 | $316K |
| IMDXInsight Molecular Diagnostics Inc. | 70,695 | $232K |
| ZURAZura Bio Ltd | 25,000 | $149K |
| CRVSCorvus Pharmaceuticals, Inc. | 10,000 | $146K |
| XLOXilio Therapeutics, Inc. | 13,800 | $116K |
| TLSITriSalus Life Sciences Inc. | 25,000 | $100K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.